Antiviral Response of HCV Genotype 1 to Consensus Interferon and Ribavirin Versus Pegylated Interferon and Ribavirin

By Sjogren Maria   Sjogren Robert   Lyons Michael   Ryan Michael   Santoro John   Smith Coleman   Reddy K.   Bonkovsky Herbert   Huntley Brooke   Faris-Young Sima  

Digestive Diseases and Sciences, Vol. 52, Iss. 6, 2007-06 ,pp. : 1540-1547

Springer Publishing Company

Access to resources Recommend Favorite

Outcome of Double-Filtration Plasmapheresis plus Interferon Treatment in Nonresponders to Pegylated Interferon plus Ribavirin Combination Therapy

By  

Digestive Diseases, Vol. 31, Iss. 5-6, 2013-11 ,pp. : 434-439

Karger

Access to resources Recommend Favorite

U.S. Multicenter Pilot Study of Daily Consensus Interferon (CIFN) Plus Ribavirin for “Difficult-to-Treat” HCV Genotype 1 Patients

By Ho Samuel   Aqel Bashar   Dieperink Eric   Liu Shanglei   Tetrick Lori   Falck-Ytter Yngve   DeComarmond Charles   Smith Coleman   McKee Daniel   Boyd William   Kulig Clark   Bini Edmund   Pedrosa Marcos  

Digestive Diseases and Sciences, Vol. 56, Iss. 3, 2011-03 ,pp. : 880-888

Springer Publishing Company

Access to resources Recommend Favorite

Retreatment of Hepatitis C with Consensus Interferon and Ribavirin After Nonresponse or Relapse to Pegylated Interferon and Ribavirin: A National VA Clinical Practice Study

By Yee Helen   Currie Sue   Tortorice Kathryn   Cozen Myrna   Shen Hui   Chapman Summer   Cunningham Fran   Monto Alexander  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2439-2448

Springer Publishing Company

Access to resources Recommend Favorite

Sustained Viral Response to Pegylated Interferon α-2b and Ribavirin in Chronic Hepatitis C Refractory to Prior Treatment

By Mathew A.   Peiffer L.   Rhoades K.   McGarrity T.  

Digestive Diseases and Sciences, Vol. 51, Iss. 11, 2006-11 ,pp. : 1956-1961

Springer Publishing Company

Access to resources Recommend Favorite